secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K
Filed at:   2025-12-18T23:59:59+00:00
Accession:  0001628280-25-057805
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor appoints former GSK CFO Simon Dingemans to board effective Jan 2, 2026
------------------------------------------------------------------------------

- Simon Dingemans elected to board effective Jan 2, 2026, filling vacancy from Jonathan Peacock's Dec 31, 2025 resignation.
- Dingemans served as CFO of GSK (2011-2019) and as Managing Director/Partner at Carlyle Group (2020-2022).
- Standard non-employee director compensation: $95K annual cash retainer plus $210K RSU grant vesting May 6, 2026.
- Dingemans also serves on boards of Vodafone Group, WPP plc, and Genomics Limited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000162828025057805/0001628280-25-057805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000162828025057805/avtr-20251217.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-057805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer